Navigation Links
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Date:4/14/2009

y exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medical Announces 2008 Year End Results
2. BioMS Medical warrant extension
3. BioMS Medical to present at BIO CEO and Investor Conference
4. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
5. BioMS Medical recognized at Scrip Awards 2008
6. BioMS Medical Announces Third Quarter 2008 Results
7. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
11. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... More than 5 million Americans are currently living ... will die with Alzheimer’s or another dementia, according to ... many Americans into looking for ways to improve their ... cognitive disorders. Jonathan Weisman, president of Biohack Pure, is ...
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 As pet owners drew ... doubt many of them wrote: "Take better care of my furry ... even designer clothes and top-brand carrying cases to take the little ... parents might also feel compelled to buy some pricey toys at ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... SANTA MONICA, Calif., May 27 Cord Blood America, Inc. ... preservation company ( http://www.cordblood-america.com ) ... to families nationwide and internationally, said today that it has ... in the first five months of 2009. "On April ...
... Microbia, Inc. (formerly Microbia Precision Engineering), an ... specialty ingredients and biomaterials from fermentation technology, ... company as vice president of process development. ... of manufacturing and process development for Bristol-Myers ...
... in German . , The enzyme ... able to rapidly ,and efficiently detoxify chemical warfare agents ... subway attacks in 1995. A detailed understanding ,of the ... for efforts aiming to improve their properties. A group ...
Cached Biology Technology:Cord Blood America Says Debt Reduced $4.194 Million in 2009 2Microbia, Inc. Names Alex Chu as Vice President of Process Development 2Structure of enzyme against chemical warfare agents determined 2
(Date:4/24/2014)... Scientific Reports journal. , CSIC researcher Carles Lalueza-Fox, ... CSIC and Pompeu Fabra University-UPF), explains: "When the Y chromosome ... it did not match with the DNA recovered from the ... and to make a functional interpretation in order to see ... , The functional genome analysis was based on two main ...
(Date:4/24/2014)... by fungus could now be treated in three days, rather ... scientists. , Cryptococcus a form of yeast ... medical research. They are found in many parts of ... mainly affect people with weakened immune systems. This infection kills ... team has tested the effects of the most commonly used ...
(Date:4/24/2014)... military veterans returning home from Iraq and Afghanistan, post-traumatic ... American medical institutions and the culture at-large. Estimates indicate ... to Iraq and Afghanistan suffer from PTSD. New research ... is shedding light on how PTSD is linked to ... rise in PTSD has implications beyond the impact of ...
Breaking Biology News(10 mins):The blood preserved in the pumpkin did not belong to Louis XVI 2Treatment for deadly yeast disease reduced to 3 days 2New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3
... PROVIDENCE, R.I. [Brown University] Perhaps variety is the very ... life, it could be the bane of existence. That,s the ... Reproduction that found men with wider variation in sperm ... that could swim well. Those with more consistently made sperm ...
... Resveratrol is a naturally occurring dietary compound found ... plants against pathogens such as bacteria and fungi ... compound was discovered in red wine in 1939 ... of the scientific community. More recently, pre-clinical studies ...
... types of bacteria responsible for causing urinary tract infections ... becoming more difficult to treat with current antibiotics, according ... project of the Center for Disease Dynamics, Economics & ... ResistanceMap, an online tool created to track changes in ...
Cached Biology News:Sperm length variation is not a good sign for fertility 2A sip of resveratrol and a full p53: Ingredients for a successful cell death 2Second most common infection in the US proving harder to treat with current antibiotics 2Second most common infection in the US proving harder to treat with current antibiotics 3Second most common infection in the US proving harder to treat with current antibiotics 4
...
... primers are designed for sequencing inserts cloned ... T7, or T3 RNA polymerase promoters, or ... supplied at a concentration of 0.1 µg/µl ... in DNA sequencing reactions using SequiTherm™ EXCEL™ ...
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
... Cytokeratin TYPE II Reacts with most ... epidermal cell keratin of 86 and 58kD ... Broad keratin reactivity is found on human ... Immunogen: Human epidermal cells ...
Biology Products: